Home › Funds › SPIREPOINT PRIVATE CLIENT, LLC › GILD
SPIREPOINT PRIVATE CLIENT, LLC position in GILD
GILEAD SCIENCES INC · Health Care
SPIREPOINT PRIVATE CLIENT, LLC reported holding 81,278 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$10.3M, representing 0.83% of its reported portfolio and ranking #33 among its reported holdings. SPIREPOINT PRIVATE CLIENT, LLC has disclosed GILD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SPIREPOINT PRIVATE CLIENT, LLC's GILD position evolved
SPIREPOINT PRIVATE CLIENT, LLC first disclosed a stake in GILD in Q1 2025 at 61,815 shares (US$6.9M). The position peaked in Q1 2026 at 80,399 shares, worth US$11.2M. Across 6 filings, SPIREPOINT PRIVATE CLIENT, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 81,278 shares valued at US$10.3M — an increase of 879 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 61.81K | $6.93M | New |
| Q2 2025 | 62.86K | $6.97M | Add |
| Q3 2025 | 65.57K | $7.28M | Add |
| Q4 2025 | 76.35K | $9.37M | Add |
| Q1 2026 | 80.40K | $11.21M | Add |
| Q2 2026 | 81.28K | $10.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on SPIREPOINT PRIVATE CLIENT, LLC
FAQ
How long has SPIREPOINT PRIVATE CLIENT, LLC held GILD?
SPIREPOINT PRIVATE CLIENT, LLC has disclosed GILD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is SPIREPOINT PRIVATE CLIENT, LLC's current position in GILD?
As of Q2 2026, SPIREPOINT PRIVATE CLIENT, LLC holds 81.28K shares of GILD (GILEAD SCIENCES INC), valued at $10.27M, representing 0.83% of its reported portfolio and ranking #33.
Has SPIREPOINT PRIVATE CLIENT, LLC been buying or selling GILD?
In the latest 13F filing (Q2 2026), SPIREPOINT PRIVATE CLIENT, LLC increased its position in GILD. The position peaked in Q1 2026 at 80.40K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.